| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 726 | NEA Arts and Artifacts Domestic Indemnity Program 2, FY2027 (12/26) See the application guidelines and instructions at arts.gov for more information. | Grant Cash Grant | United States | Award range: $10,000 - $100,000 | Open Jun 7, 2027 Open | Grants.gov |
|
Source description
See the application guidelines and instructions at arts.gov for more information. |
||||||
| 727 | NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) encourages applications for support of resources that will provide access to state-of-th... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jun 14, 2027 Open | Grants.gov |
|
Source description
This Notice of Funding Opportunity (NOFO) encourages applications for support of resources that will provide access to state-of-the-art equipment, technologies, research tools, materials, organisms, software, and/or services to a substantial regional (multi-state) or national user base. Only those resources with technical capabilities that fall within the NIGMS-supported program areas are eligible for awards. The resources should already be established or may be formed through consolidation of existing local or regional facilities. The intent is to provide resource access to investigators without regard to the specific biomedical focus of their research, while not duplicating or replacing resources supported by sources such as other NIH Institutes and Centers (ICs) or host institutions. The resource is expected to be maintained or upgraded to current best practices, make its capabilities and availability known to the biomedical research community through a robust web presence and outreach activities, and provide user training and support. |
||||||
| 728 | Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jun 17, 2027 Open | Grants.gov |
|
Source description
The National Institute on Deafness and other Communication Disorders (NIDCD) intends to re-issue a Notice of Funding Opportunity (NOFO, prior funding opportunity RFA-DC-24-008 to solicit applications for research on early-stage dissemination and implementation (D&I) in the NIDCD mission areas of hearing, balance, taste, smell, voice, speech, and language. Much research is devoted to developing evidence-based innovations (EBIs) that improve a person"s health and quality of life. To impact people"s lives, EBIs need to be adopted in clinical practice and everyday life. Unfortunately, wide-scale adoption of EBIs is lengthy and rare. Dissemination and implementation (D&I) science is the field of research that seeks to close the gap between research and practice. Dissemination research is defined as the scientific study of the targeted distribution of information and materials about EBI to a specific audience (e.g., practitioners, patients, policymakers). The intent is to understand how best to communicate and integrate knowledge associated with a given EBI. Implementation Science refers to a broader array of active and planned efforts to integrate evidence into practice. Implementation research focuses on understanding why clinical and community settings are not adopting and sustaining a particular EBI. In turn, implementation research uses this understanding of barriers and facilitators to develop and evaluate different strategies (or collections of strategies) to increase adoption and integration of an EBI into practice. Many fields have applied D&I research theories, approach... |
||||||
| 729 | Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jul 2, 2027 Open | Grants.gov |
|
Source description
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning. |
||||||
| 730 | NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) To provide highly qualified postdoctoral fellows and other doctoral-level researchers currently in training in the NHLBI Division... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jul 12, 2027 Open | Grants.gov |
|
Source description
To provide highly qualified postdoctoral fellows and other doctoral-level researchers currently in training in the NHLBI Division of Intramural Research with the opportunity to transition their research programs to extramural institutions as junior investigators. |
||||||
| 731 | Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) The National Institutes of Health (NIH) hereby notifies recipient organizations holding specific types of NIH grants, listed withi... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jul 12, 2027 Open | Grants.gov |
|
Source description
The National Institutes of Health (NIH) hereby notifies recipient organizations holding specific types of NIH grants, listed within the Activity Code section above, that applications for change of recipient organization may be submitted to this NOFO. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission. |
||||||
| 732 | NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Di... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jul 12, 2027 Open | Grants.gov |
|
Source description
The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research the opportunity to transition their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee's research program during the mentored phase as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. |
||||||
| 733 | Successor-in-Interest (Type 6 Parent Clinical Trial Optional) The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jul 17, 2027 Open | Grants.gov |
|
Source description
The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this NOFO. Applications for change of recipient organization status are considered prior approval requests (as described in Section 8.1.2.8 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award.Although successor-in-interest requests may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission. |
||||||
| 734 | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or c... | Grant Cash Grant | United States | Award ceiling: $150,000 | Open Aug 11, 2027 Open | Grants.gov |
|
Source description
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. |
||||||
| 735 | NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public heal... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers. |
||||||
| 736 | Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets. |
||||||
| 737 | Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets. |
||||||
| 738 | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof. |
||||||
| 739 | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof. |
||||||
| 740 | Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25,... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities. |
||||||
| 741 | D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of... | Grant Cash Grant | United States | Award ceiling: $100,000 | Open Sep 7, 2027 Open | Grants.gov |
|
Source description
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects. |
||||||
| 742 | NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) The purpose of this Notice of Funding Opportunity (NOFO) is to support the continued operation, maintenance, and dissemination of... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 25, 2027 Open | Grants.gov |
|
Source description
The purpose of this Notice of Funding Opportunity (NOFO) is to support the continued operation, maintenance, and dissemination of unique database bioinformatics resources that are of major importance to the research community using animal models of embryonic developmental processes. These grants will support ongoing development and enhancement of the resources, user training and services, provision of community generated data storage and curation, wide dissemination of the tools and/or resources, and expansion of interoperability with other NIH bioinformatics resources. |
||||||
| 743 | Support for the functioning of SEAPs, including for the purpose of establishing, managing and maintaining defence industrial readiness pools Expected Impact:Supported SEAPs are expected to rent office space, recruit personnel and start and uphold operations for a duratio... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Sep 28, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:Supported SEAPs are expected to rent office space, recruit personnel and start and uphold operations for a duration of at least one year.Objective:This call aims to provide support for functioning of established SEAPs, including for the purpose of establishing, managing and maintaining defence industrial readiness pools.Scope:Proposals shall aim to support established SEAPs in their initial operations for a duration of at least one year.BudgetThe Commission is considering a total budget of EUR 10 000 000 for the call for proposals. The maximum EU contribution per funded project will not exceed EUR 2 000 000 allowing several proposals to be funded. Depending on the number and quality of received proposals and the requested Union financial contributions, the Commission may decide to reallocate budget between calls |
||||||
| 744 | Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) progra... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 28, 2027 Open | Grants.gov |
|
Source description
The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Notice of Funding Opportunity (NOFO) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars who have made a commitment to independent clinical and translational science research careers (i.e., tenure-track or equivalent faculty positions)to facilitate their timely career advancementand continued engagement in research (i.e., sectors including academia, industry, nonprofit and government). |
||||||
| 745 | Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (N... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 28, 2027 Open | Grants.gov |
|
Source description
The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to create, provide, and disseminate clinical and translational science training and career support programs that enhance postdoctoral research training of individuals with doctoral degrees (these include, but are not limited to, the following: D.M.D., DC, DO, DVM., OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND [Doctor of Naturopathy], DSW, PsyD, as well as a doctoral degree in nursing research) and help ensure a heterogenous pool of clinical and translational scientists trainees who are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health and support meaningful translational science research projects that address demonstrable needs among stakeholder communities. |
||||||
| 746 | Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (N... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 28, 2027 Open | Grants.gov |
|
Source description
The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligibleinstitutions to create, provide, and disseminate clinical and translational science training and career support programs for individuals seeking a PhD or an equivalent research health professional degree and help ensure a heterogenous pool of clinical and translational scientist trainees who are equipped with the knowledge, skills and abilities (KSAs) to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications aimed at improving health and support meaningful translational science research projects that address demonstrable needs among stakeholder communities. |
||||||
| 747 | Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching g... | Grant Cash Grant | United States | Award ceiling: $250,000 | Open Sep 29, 2027 Open | Grants.gov |
|
Source description
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences. |
||||||
| 748 | NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scienti... | Grant Cash Grant | United States | Award ceiling: $500,000 | Open Oct 12, 2027 Open | Grants.gov |
|
Source description
This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. |
||||||
| 749 | NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctor... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Oct 14, 2027 Open | Grants.gov |
|
Source description
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers. |
||||||
| 750 | NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctor... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Oct 14, 2027 Open | Grants.gov |
|
Source description
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers. |
||||||